This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cleerly is dedicated to creating a new standard of care for heartdisease by using FDA-cleared solutions powered by artificial intelligence. We are very excited to see our purpose-driven mission come to life, making advanced cardiac care accessible to more patients and working towards our goal of eliminating heartattacks.” “We
If you do not have coronaryarterydisease the probability of you dying from it then is very low. The factors that we have discussed so far are all important risk factors for developing coronaryarterydisease. You decide. You measure.
But What About Stress & HeartDisease? When stress is included in the risk factor profile for a future heartattack, it comes in third on the list after abnormal cholesterol and smoking 1. 24% increased risk of coronaryarterydisease. Bring back the real emergencies, I say! The link is real.
Diamond and Forrester accomplished this by first establishing the prevalence of coronaryarterydisease based on how clinically likely patients with chest pain symptoms were found to have coronarydisease based on a coronary angiogram. Thanks for reading Dr. Anish Koka's Newsletter!
Getty Images milla1cf Mon, 04/29/2024 - 13:06 April 29, 2024 — Women with heartdisease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024 , a scientific congress of the European Society of Cardiology ( ESC ).1 2Knuuti J, Wijns W, Saraste A, et al.
Healy, MD, FACC, published an editorial in the New England Journal of Medicine highlighting the findings of two studies in that issue demonstrating clear evidence of sex bias in the management of coronaryarterydisease.2 These have ranged from heartattacks, cardio-obstetrics, breast cancer, prevention and arrhythmias.8-13
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content